Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

AccurKardia converts ECG signals into a diagnostic biomarker to help clinicians detect cardiovascular and metabolic conditions earlier. Its cloud-based platform includes AccurECG, an FDA-cleared…

AccurKardia converts ECG signals into a diagnostic biomarker to help clinicians detect cardiovascular and metabolic conditions earlier. Its cloud-based platform includes AccurECG, an FDA-cleared…
What they do: AI-driven ECG diagnostic software (AccurECG, AK-AVS, AK+ Guard)
Regulatory status: AccurECG: FDA-cleared Class II SaMD; AK-AVS and AK+ Guard: FDA Breakthrough Device designations
Business model: B2B SaaS integrating with clinical workflows
Founded: 2019
Reported total funding: USD 14,070,000
Cardiovascular diagnostics; early detection of cardiac and metabolic conditions from ECG data.
2019
Data and Analytics
450000
Reported seed round
1400000
Reported seed round
2700000
Reported seed round
Public profiles list additional early seed financings and investors across multiple rounds
“Mayo Clinic; MedTech Innovator; Popular Impact Fund; Root NYC”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,300+
New This Week